[Form 4] Health In Tech, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Timothy Hayes, Director of Health In Tech (HIT), acquired 128,474 shares of Class A Common Stock on June 23, 2025, at a price of $0.62 per share through a restricted stock grant under the company's Equity Incentive Plan.

Key vesting terms:

• Full vesting after one year of service from December 23, 2024
• Alternative partial vesting at first shareholders' meeting based on service time ratio
• Vesting conditional on continuous service through vesting date

The transaction was reported via Form 4 filing on June 25, 2025, within the required reporting window. This equity grant aligns the director's interests with shareholders and serves as part of the company's executive compensation strategy.

Positive

• Director Timothy Hayes received 128,474 restricted shares worth approximately $79,654 ($0.62 per share), aligning his interests with shareholders through a one-year vesting schedule

Negative

• None.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hayes Timothy

(Last) (First) (Middle)

701 S. COLORADO AVE, SUITE 1

(Street)

STUART FL 34994

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/23/2025		A		128,474(1)	A	$0.62	128,474	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest either (i) fully upon one year of service commencing on December 23, 2024, or (ii), if not vested upon such date, partially vest at the first shareholders' meeting, with the number of vested shares determined by multiplying the total number of restricted stock by a ratio with the numerator being the lesser of the period of time since December 23, 2024 and 12 months and the denominator being 12 months, subject to the reporting person's continuous service through the vesting date.

	By Timothy Hayes /s/ Timothy Hayes	06/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares of HIT stock did Director Timothy Hayes acquire on June 23, 2025?

Director Timothy Hayes acquired 128,474 shares of HIT Class A Common Stock on June 23, 2025 at a price of $0.62 per share through a restricted stock grant.

What are the vesting terms for Timothy Hayes's HIT restricted stock grant?

The restricted shares vest either (i) fully after one year of service from December 23, 2024, or (ii) partially at the first shareholders' meeting if not fully vested, with partial vesting calculated as a ratio of time served since December 23, 2024 (up to 12 months) divided by 12 months, subject to continuous service.

What is Timothy Hayes's role at HIT (Health In Tech, Inc.)?

According to the Form 4 filing, Timothy Hayes serves as a Director of Health In Tech, Inc. (HIT). This is indicated by the 'X' marked in the Director box under the relationship section of the filing.

What was the total value of HIT restricted stock granted to Timothy Hayes?

The total value of the restricted stock grant was approximately $79,654, calculated by multiplying 128,474 shares by the reported price of $0.62 per share.

When did Timothy Hayes sign this Form 4 for HIT stock acquisition?

Timothy Hayes signed the Form 4 on June 25, 2025, two days after the transaction date of June 23, 2025, and three days before the filing date of June 28, 2025.